A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 1, 2006, Pages 57-62

  Obrador, Blai Dalmau ^a,c   Prades, Montserrat Gil ^a   Gomez, Mercedes Vergara ^a   Domingo, Jordi Puig ^a   Cueto, Rosa Bella ^b   Rué, Montserrat ^b   Real, Jordi ^b   Guiteras, Pere Mas ^a  

^a PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^b Parc Tauli Health Corporation   (Spain)

^c Unitat de Malalties Digestives   (Spain)

Author keywords

Chronic hepatitis C; Cirrhosis; Index score

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; ECHOGRAPHY; FEMALE; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER ATROPHY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY; THROMBIN TIME; THROMBOCYTE COUNT; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; PLATELET COUNT; PROGNOSIS; PROTHROMBIN TIME; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 29344474727     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200601000-00010     Document Type: Article

References (28)

1. WHO. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention Board, Antwerp, Belgium. J Viral Hepatol 1999; 6:35-47.
2. Centers for Disease Control and Prevention. Expert panel. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morb Mortal Wkly Rep 1998; 47:1-17.
3. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States 1988 through 1994. N Engl J Med 1999; 341:556-562.
4. Mattson L. Chronic non-A non B hepatitis. Scand J Infect Dis 1989; 59 (suppl):3-55.
5. Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A, et al. Long term follow up of post transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus. J Hepatol 1990; 10:69-76.
6. Mattson L, Weiland O, Glaummann H. Chronic non-A, non-B hepatitis developed after transfusion, illicit self injections or sporadically. Outcome during long-term follow-up - a comparison. Liver 1989; 9:120-127.
7. Seff LB, National Hear, Lung, and Blood Institute Hepatitis Study Group. Mortality of non-A, non-B transfusion associated hepatitis in the U.S. 18 years after infection. Hepatology 1991; 14:90 (Abstract).
8. Ghany MG, Leiner DE, Alter H, Doo E, Khokar F, Promrat K, et al. Progession of fibrosis in chronic hepatitis C. Gastroenterology 2003; 124:97-104.
9. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-S46.
10. Consensus Statement. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999; 31:3-8.
11. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002; 36:S57-S64.
12. McCormick SE, Goodman ZD, Maydenovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996; 91:1516-1524.
13. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26:57S-61S.
14. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepaitis C. Hepatology 2001; 33:196-200.
15. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998; 93:44-48.
16. Reedy DW, Loo AT, Levine RA. AST/ALT ratio ≥ 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Digestive Dis Sci 1998; 43:2156-2159.
17. Kaul V, Friedenberg FK, Braitman LE, Anis U, Zaeri N, Fazilli J, et al. Development and validation of a model to diagnose cirrhosis in patients with hepatitis C. Am J Gastroenterol 2002; 97:2623-2628.
18. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-1616.
19. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quinto LL, Martinez E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36:986-992.
20. Bonacini M, Hadi G, Govindarajan S, Lindsay L. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997; 92:1302-1304.
21. Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection - analysis of 300 cases. Radiology 2003; 227:89-94.
22. Aubé C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30:472-478.
23. Gaiani S, Gramantieri L, Venturoli N, Piscaglia F, Siringo S, D'Errico A, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography an percutaneous liver biopsy. J Hepatol 1997; 27:979-985.
24. Knodell RG, Ishack KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
25. Harrell FE, Lee KL, Mark DB. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-367.
26. Pagliaro L, Rinaldi F, Craxi A, Di Piazza S, Filippazzo G, Gatto G, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective randomized trial. Dig Dis Sci 1983; 28:39-43.
27. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1:523-525.
28. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999; 30:1356-1362.